Ireland· IE-PA-EU/1/26/2018/001-008
Ilumira 37 GBq/mL radiopharmaceutical precursor, solution
A other therapeutic radiopharmaceuticals product containing lutetium (177lu) chloride, registered in Ireland by SHINE Europe B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) chloride is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Lutetium (177lu) chloride · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Lutetium (177lu) chloride
- Manufacturer
- SHINE Europe B.V.
- Country
- Ireland (IE)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/26/2018/001-008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) chloride in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- SwedenEndolucinBeta 40 GBq/ml Stamlösning till radioaktiva läkemedelITM Medical Isotopes GmbH
- GermanyLutencaCurium Romania Srl
- PolandIlumiraSHINE Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Lutenca
- Belgium · Monlutenca
- Germany · Lutenca
- Spain · Lutenca
- France · Lunca
- United Kingdom (Northern Ireland) · Monlutenca
- Iceland · Endolucinbeta, Ilumira
- Italy · Monlunca
- Liechtenstein · Endolucinbeta, Ilumira
- Netherlands · Monlutenca
- Norway · Endolucinbeta, Ilumira
- Portugal · Lutenca
- Sweden · Lutenca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc85aaa3-3195-4eac-8c36-e7bea4244356 GET /v1/drugs/dc85aaa3-3195-4eac-8c36-e7bea4244356?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Radiopharmaceutical precursor, solution",
"routes": [
"Route of administration not applicable"
],
"source": "hpra",
"atc_all": [
"V10X"
],
"strength": null,
"pa_number": "EU/1/26/2018/001-008",
"substances": [
"Lutetium (177lu) chloride"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/03/2026",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lutetium (177lu) chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.